• Categories:News
• Author:FORECYTE
• Origin:Forecyte Bio Shanghai Limited
• Time of issue:2022-07-13 18:34
• Views:

Based on the professional industry experience and technical strength, in line with the original intention of "high-quality, efficient, flexible, and accelerating the process of patients using cutting-edge gene and cell therapy solutions", Forecyte brings its expertise in the field of cell and gene therapy, innovative CDMO4*4 service model, and demonstrated the important technical concept "Pharmaceutical Manufacturing through Technology Transfer" at the ATMP Summit.